Clinical Trials Logo

Arthroplasty Complications clinical trials

View clinical trials related to Arthroplasty Complications.

Filter by:

NCT ID: NCT03826108 Recruiting - Clinical trials for Arthroplasty Complications

ARTHR-IS (Arthroplasties' Infections Due to Staphylococcus Aureus)

Start date: April 16, 2019
Phase:
Study type: Observational

The number of arthroplasties is expected to grow in the next few years. Staphylococcus aureus (SA) is a primary cause of prosthetic joint infection (PJI) with serious consequences. This microorganism is frequently associated with treatment failure, hospitalizations and need of prosthesis removal, leading to an important morbidity and an increase in healthcare costs. ARTHR-IS is a retrospective multi-center study which aims to estimate the burden of SA-PJI after a hip or knee arthroplasty and their risk factors. Other objectives are to quantify the costs, the number of hospitalizations and the surgical procedures needed to treat and control the infection and finally the factors influencing therapeutic failure. Through a case-control design, ARTHR-IS will group 20 hospitals across 5 European countries in order to include 150 cases and 450 controls. The results of this study will provide critical information to develop strategies to prevent and treat SA-PJI and reduce treatment failures. Also, the results from ARTH-IS study will help in the design of future clinical trials in prosthesis infections by providing reliable estimates on the incidence of SA-PJI and the subsequent burden on health care services.

NCT ID: NCT03306810 Recruiting - Clinical trials for Arthroplasty Complications

Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service

AGS
Start date: September 26, 2017
Phase: N/A
Study type: Interventional

AGS (Acute Glucose Service ) is an inpatient glucose management service consisting of Nurse Practitioner and physician. Team manages not - consulted- based preoperative assessment, perioperative glucose control, patient education and supervision, but also transition of care postoperatively. The goal is to detect and treat dysglycemias , but also provide an active and constantly ongoing education to other hospital teams. AGS improves better overall- survival of arthroplastic patients and is an effective way to recognize and treat dysglycemias and to organize constantly ongoing education.